ClinConnect ClinConnect Logo
Search / Trial NCT05151003

Epidemiology of In-hospital Acute Kidney Injury

Launched by UNIVERSITA DEGLI STUDI DI GENOVA · Nov 26, 2021

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at a condition called acute kidney injury (AKI) in patients who have been hospitalized at University Hospital San Martino in Genova, Italy. AKI is when the kidneys suddenly stop working well, which can happen for various reasons, including complications from other illnesses like COVID-19. The study aims to understand how common AKI is among hospitalized patients and what happens to them after they develop this condition.

To be eligible for this study, patients must be admitted to the hospital and can be from a wide age range, typically between 65 and 74 years old, regardless of gender. Patients who are on hemodialysis, a treatment for kidney failure, will not be included. If you or a loved one is part of this trial, you can expect that the researchers will review medical records to gather information about your kidney health during your hospital stay. This study is important because it will help doctors better understand AKI and improve care for future patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients admitted to University Hospital San Martino, Italy
  • We'll include also patients affected by Coronavirus disease 19 (COVID-19).
  • Exclusion Criteria:
  • Hemodialysis patients

About Universita Degli Studi Di Genova

The Università degli Studi di Genova, located in Italy, is a prestigious academic institution renowned for its commitment to advancing scientific research and education. With a strong focus on interdisciplinary collaboration, the university actively engages in clinical trials aimed at improving healthcare outcomes across various medical fields. Its dedicated research teams leverage cutting-edge technology and innovative methodologies to explore novel therapeutic approaches, contributing to the global body of knowledge in medicine. The university's emphasis on high ethical standards ensures that all clinical trials are conducted with the utmost integrity and respect for participant welfare.

Locations

Genova, , Italy

Patients applied

0 patients applied

Trial Officials

Pasquale Esposito, Prof

Principal Investigator

University of Genova, Italy

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials